This finding is consistent with the notion that non-specific measures of neurodegeneration (MRI, plasma NfL), may be sensitive to non-AD related longitudinal change in the brain structure and cognition while more AD-specific measures (plasma p-tau181) are predictive of progression within the AD continuum. The gene discussed is NEFL; the disease is Alzheimer disease.